PHLDA3 and thymus lymphoma: However, using a mouse model of radiation-induced thymic lymphoma, which has been robustly used to study p53-mediated tumor suppression, our results show that deletion of Phlda3 does not alter the incidence and latency of thymic lymphomas induced by 1.8 Gy × 4 TBI (Fig. 3).